Human Growth Hormone Market Overview
The global Human Growth Hormone market is expected to rise at a considerable rate in the forthcoming years on the back of the increase in awareness about the effectiveness of growth hormones and the growing prevalence of chronic diseases.
Human growth hormone is a peptide hormone that is responsible for cell creation, growth stimulation, and cell regeneration in the human body. It plays an important part in the human body's growth. Human growth hormones have a lot of advantages; thus, they'll have a lot of growth potential over the next few years. The rising prevalence of human development problems has raised awareness of the significance of therapy among a huge portion of the global population, resulting in a significant increase in the market for human growth hormones.
The creation of a strong research and development program is important to the success of the human growth hormone market. The participants in the human growth hormone market put a lot of money into these operations in order to find new formulations that will help them increase their profits. The players are also engaged in expansion initiatives, which are expected to raise the market for human growth hormones even more.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Route of Administration, Distribution Channel, Indication, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | AMerck KGaA, Pfizer Inc., Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A, GeneScience Pharmaceuticals Co., Ltd., Roche Holdings, Inc. |
Covid-19 Impact on Human Growth Hormone Market
In addition, the current Human Growth Hormone Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Human Growth Hormone Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Human Growth Hormone Market Segment Overview
According to Route of Administration, Subcutaneous is a major segment in the global Human Growth Hormone market. The subcutaneous method is becoming more popular since it results in a large increase in growth rates and a low incidence of antibody formation. Furthermore, for prolonged growth hormone therapy, the subcutaneous route is highly preferable. By Distribution Channel, Hospital Pharmacy is one of the largest segments in the global market. A number of hospital pharmacies are distributing medications due to the high cost of human growth hormone drugs. In addition, governments in various countries are investing heavily in the establishment of modern healthcare facilities and hospitals, which is pushing the distribution of growth hormone medications through hospital pharmacies.
Human Growth Hormone Market, By Route of Administration
· Intravenous
· Subcutaneous
· Intramuscular
· Oral
Human Growth Hormone Market, By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Clinics
Human Growth Hormone Market, By Indication
· Growth Hormone Deficiency
· Turner Syndrome
· Idiopathic Short Stature
· Prader-Willi Syndrome
· Other
Human Growth Hormone Regional Overview
Based on the region, North America held the largest share in the global Human Growth Hormone market. The presence of key market players, as well as the FDA's approval of growth hormone for commercial use, are propelling the market forward. As well, the market in the Asia Pacific is projected to enlarge at a higher level in the coming years. India, China, and Australia are all contributing to the region's growth. Furthermore, the growing number of persons suffering from growth hormone deficiency creates a potential for the region's leading companies
Human Growth Hormone Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Human Growth Hormone Market, Key Players
· Merck KGaA
· Pfizer Inc.
· Eli Lilly and Company
· Novartis AG
· Novo Nordisk A/S
· Anhui Anke Biotechnology (Group) Co., Ltd
· Biopartners GmbH
· Ipsen S.A
· GeneScience Pharmaceuticals Co., Ltd.
· Roche Holdings, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Human Growth Hormone market?
The increase in awareness about the effectiveness of growth hormones and the growing prevalence of chronic diseases are important factors that positively impact the growth of the market
Q2. Which Segments are covered in the global Human Growth Hormone market report?
Route of Administration, Distribution Channel, Indication, and Region. these segments are covered in the global Human Growth Hormone market report.
Q3. Which segment is projected to hold the largest share in the global Human Growth Hormone market?
Subcutaneous segments are projected to hold the largest share in the global Human Growth Hormone market.
Q4. Which region holds the largest share in the global Human Growth Hormone market?
North America held the largest share in the global Human Growth Hormone market.
Q5. Which are the prominent players in the global Human Growth Hormone market?
Merck KGaA, Pfizer Inc., Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co., Ltd, Biopartners GmbH, Ipsen S.A, GeneScience Pharmaceuticals Co., Ltd., Roche Holdings, Inc. are some key players in the global Human Growth Hormone market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Route of Administration
- 5.2.1. Intravenous
- 5.2.2. Subcutaneous
- 5.2.3. Intramuscular
- 5.2.4. Oral
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Hospital Pharmacy
- 5.3.2. Retail Pharmacy
- 5.3.3. Online Pharmacy
- 5.3.4. Clinics
- 5.4. Market Analysis, Insights and Forecast – By Indication
- 5.4.1. Growth Hormone Deficiency
- 5.4.2. Turner Syndrome
- 5.4.3. Idiopathic Short Stature
- 5.4.4. Prader-Willi Syndrome
- 5.4.5. Other
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Route of Administration
- 6.2.1. Intravenous
- 6.2.2. Subcutaneous
- 6.2.3. Intramuscular
- 6.2.4. Oral
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Hospital Pharmacy
- 6.3.2. Retail Pharmacy
- 6.3.3. Online Pharmacy
- 6.3.4. Clinics
- 6.4. Market Analysis, Insights and Forecast – By Indication
- 6.4.1. Growth Hormone Deficiency
- 6.4.2. Turner Syndrome
- 6.4.3. Idiopathic Short Stature
- 6.4.4. Prader-Willi Syndrome
- 6.4.5. Other
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Route of Administration
- 7.2.1. Intravenous
- 7.2.2. Subcutaneous
- 7.2.3. Intramuscular
- 7.2.4. Oral
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Hospital Pharmacy
- 7.3.2. Retail Pharmacy
- 7.3.3. Online Pharmacy
- 7.3.4. Clinics
- 7.4. Market Analysis, Insights and Forecast – By Indication
- 7.4.1. Growth Hormone Deficiency
- 7.4.2. Turner Syndrome
- 7.4.3. Idiopathic Short Stature
- 7.4.4. Prader-Willi Syndrome
- 7.4.5. Other
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Route of Administration
- 8.2.1. Intravenous
- 8.2.2. Subcutaneous
- 8.2.3. Intramuscular
- 8.2.4. Oral
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Hospital Pharmacy
- 8.3.2. Retail Pharmacy
- 8.3.3. Online Pharmacy
- 8.3.4. Clinics
- 8.4. Market Analysis, Insights and Forecast – By Indication
- 8.4.1. Growth Hormone Deficiency
- 8.4.2. Turner Syndrome
- 8.4.3. Idiopathic Short Stature
- 8.4.4. Prader-Willi Syndrome
- 8.4.5. Other
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Human Growth Hormone Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Route of Administration
- 9.2.1. Intravenous
- 9.2.2. Subcutaneous
- 9.2.3. Intramuscular
- 9.2.4. Oral
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Hospital Pharmacy
- 9.3.2. Retail Pharmacy
- 9.3.3. Online Pharmacy
- 9.3.4. Clinics
- 9.4. Market Analysis, Insights and Forecast – By Indication
- 9.4.1. Growth Hormone Deficiency
- 9.4.2. Turner Syndrome
- 9.4.3. Idiopathic Short Stature
- 9.4.4. Prader-Willi Syndrome
- 9.4.5. Other
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Merck KGaA
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Pfizer Inc.
- 10.6. Eli Lilly and Company
- 10.7. Novartis AG
- 10.8. Novo Nordisk A/S
- 10.9. Anhui Anke Biotechnology (Group) Co., Ltd
- 10.10. Biopartners GmbH
- 10.11. Ipsen S.A
- 10.12. GeneScience Pharmaceuticals Co., Ltd.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
